Wellview Pathology & Research Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.30 M
- Company Age 11 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.40 M
- Revenue Growth -50.13%
- Profit Growth -63.75%
- Ebitda -44.88%
- Net Worth 10.79%
- Total Assets -16.56%
About Wellview Pathology & Research
Wellview Pathology & Research Private Limited (WPRPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 March 2013 and has a history of 11 years and 11 months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹0.40 M.
Devendra Prasad and Birendra Dangi serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74140BR2013PTC019968
- Company No.
019968
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Wellview Pathology & Research?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devendra Prasad  | Director | 08-Mar-2013 | Current |
| Birendra Dangi | Director | 08-Mar-2013 | Current |
Financial Performance of Wellview Pathology & Research.
Wellview Pathology & Research Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 50.13% decrease. The company also saw a substantial fall in profitability, with a 63.75% decrease in profit. The company's net worth Soared by an impressive increase of 10.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellview Pathology & Research?
In 2018, Wellview Pathology & Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Florence Multiventures India Private LimitedBirendra Dangi is a mutual person
- Taad Energy Private Limited
Birendra Dangi is a mutual person
Charges (Loans)
₹0.40 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 May 2015 | Bank Of Baroda | ₹0.40 M | Open |
How Many Employees Work at Wellview Pathology & Research?
Unlock and access historical data on people associated with Wellview Pathology & Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellview Pathology & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellview Pathology & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.